Observational studyJAMA neurology2022

Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.

Emilio Portaccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.